The multiple faces of quercetin in neuroprotection

Author： Ossola Bernardino Kääriäinen Tiina M Männistö Pekka T

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.4, 2009-07, pp. : 397-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration and Neuroprotection in Multiple Sclerosis

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4471-4474

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

By Neuhaus O. Archelos J.J. Hartung H.-P.

Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1775-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Excitotoxicity and neuroprotection

By Krieglstein J.

European Journal of Pharmaceutical Sciences, Vol. 5, Iss. 4, 1997-07 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite

Bilobalide and Neuroprotection

By Defeudis F.V.

Pharmacological Research, Vol. 46, Iss. 6, 2002-12 ,pp. : 565-568

Academic Press

Access to resources Recommend Favorite